Prosight Management, LP 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Prosight Management, LP disclosed 46 US equity positions worth $609.8m in its Q1 2026 13F filing. The largest position was NKTR at 8.7% of the reported book, followed by BSX and JANX.
What did Prosight Management, LP own in Q1 2026? Top 46 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | NKTR NEKTAR THERAPEUTICS | Healthcare | 8.7% | $52.9m | 735,000 | – | |
| 2 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 8.2% | $49.9m | 795,547 | – | |
| 3 | JANX JANUX THERAPEUTICS INC | Healthcare | 8.1% | $49.3m | 3,550,000 | – | |
| 4 | PRCT PROCEPT BIOROBOTICS CORP | Healthcare | 8.0% | $48.6m | 1,945,000 | – | |
| 5 | LKFT GALAPAGOS NV | Healthcare | 7.6% | $46.5m | 1,550,000 | – | |
| 6 | WGS GENEDX HOLDINGS CORP | Healthcare | 5.5% | $33.6m | 523,463 | – | |
| 7 | STTK SHATTUCK LABS INC | Healthcare | 5.3% | $32.2m | 5,004,439 | – | |
| 8 | ADCT ADC THERAPEUTICS SA | Healthcare | 5.1% | $31.1m | 8,300,000 | – | |
| 9 | KURA KURA ONCOLOGY INC | Healthcare | 4.5% | $27.3m | 3,356,700 | – | |
| 10 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 4.1% | $25.1m | 76,000 | – | |
| 11 | MGTX MEIRAGTX HLDGS PLC | Healthcare | 3.7% | $22.8m | 2,629,971 | – | |
| 12 | ALKS ALKERMES PLC | Healthcare | 3.0% | $18.2m | 513,632 | – | |
| 13 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 2.9% | $18.0m | 770,000 | – | |
| 14 | VEEV VEEVA SYS INC | Healthcare | 2.5% | $15.2m | 86,480 | – | |
| 15 | ZYME ZYMEWORKS INC | Healthcare | 2.2% | $13.5m | 539,049 | – | |
| 16 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 2.1% | $12.7m | 350,000 | – | ||
| 17 | ABVX ABIVAX SA | Healthcare | 1.9% | $11.7m | 105,000 | – | |
| 18 | CON CONCENTRA GROUP HOLDINGS PAR | 1.8% | $10.8m | 505,822 | – | ||
| 19 | 430 TERNS PHARMACEUTICALS INC | 1.7% | $10.7m | 202,300 | – | ||
| 20 | PHR PHREESIA INC | Healthcare | 1.5% | $9.2m | 1,100,000 | – | |
| 21 | OKUR ONKURE THERAPEUTICS INC | 1.5% | $8.9m | 2,154,381 | – | ||
| 22 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 1.1% | $6.5m | 697,108 | – | |
| 23 | SDGR SCHRODINGER INC | Healthcare | 1.0% | $5.8m | 510,578 | – | |
| 24 | EBS EMERGENT BIOSOLUTIONS INC | Healthcare | 0.9% | $5.3m | 639,118 | – | |
| 25 | ROIV ROIVANT SCIENCES LTD | Healthcare | 0.8% | $5.0m | 180,000 | – | |
| 26 | KIDS ORTHOPEDIATRICS CORP | Healthcare | 0.8% | $4.8m | 302,399 | – | |
| 27 | IMVT IMMUNOVANT INC | Healthcare | 0.7% | $4.4m | 175,825 | – | |
| 28 | ICUI ICU MED INC | Healthcare | 0.6% | $3.5m | 27,450 | – | |
| 29 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.4% | $2.5m | 79,872 | – | |
| 30 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 0.4% | $2.4m | 683,856 | – | |
| 31 | UPB UPSTREAM BIO INC | 0.4% | $2.2m | 241,123 | – | ||
| 32 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 0.3% | $2.1m | 1,667,600 | – | |
| 33 | OMER OMEROS CORP | 0.3% | $1.8m | 174,800 | – | ||
| 34 | ISRG INTUITIVE SURGICAL INC | Healthcare | 0.3% | $1.8m | 4,000 | – | |
| 35 | ANTX AN2 THERAPEUTICS INC | 0.3% | $1.8m | 515,754 | – | ||
| 36 | ACET ADICET BIO INC | 0.3% | $1.7m | 250,244 | – | ||
| 37 | RGNX REGENXBIO INC | Healthcare | 0.3% | $1.7m | 200,000 | – | |
| 38 | COYA COYA THERAPEUTICS INC | 0.3% | $1.7m | 420,360 | – | ||
| 39 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.2% | $1.5m | 45,000 | – | |
| 40 | IRTC IRHYTHM HOLDINGS INC | Healthcare | 0.2% | $1.2m | 10,000 | – | |
| 41 | TBI TRUEBLUE INC | Industrials | 0.2% | $974.0k | 249,107 | – | |
| 42 | IMRX IMMUNEERING CORP | 0.1% | $650.4k | 123,409 | – | ||
| 43 | PVLA PALVELLA THERAPEUTICS INC NE | Healthcare | 0.1% | $623.2k | 5,000 | – | |
| 44 | NVCR NOVOCURE LTD | Healthcare | 0.1% | $549.4k | 50,400 | – | |
| 45 | RNTX REIN THERAPEUTICS INC | 0.1% | $535.1k | 411,600 | – | ||
| 46 | TMDX TRANSMEDICS GROUP INC | Healthcare | 0.1% | $497.1k | 5,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.